← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2014Last known activity
May 5, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (9 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (15)
- NCT06963294Sponsor investigatorN/AMay 5, 2026
- NCT07277283Sponsor investigatorPhase 4Feb 1, 2025
- NCT07277283OfficialPhase 4Feb 1, 2025
- NCT07277283Lead sponsorPhase 4Feb 1, 2025
- NCT06741930Lead sponsorPhase 4Dec 1, 2024
- NCT06741930Sponsor investigatorPhase 4Dec 1, 2024
- NCT06494007OfficialPhase 4Jan 1, 2023
- NCT06494007Sponsor investigatorPhase 4Jan 1, 2023
- NCT06494007Lead sponsorPhase 4Jan 1, 2023
- NCT05947435Lead sponsorN/AJan 1, 2022
- NCT05947435Reponsible party - principal investigatorN/AJan 1, 2022
- NCT04628676Lead sponsorN/AFeb 1, 2017
- NCT04628676Reponsible party - principal investigatorN/AFeb 1, 2017
- NCT02350985Reponsible party - principal investigatorPhase 4Jan 1, 2014
- NCT02350985Lead sponsorPhase 4Jan 1, 2014
Details
- Last known activity
- May 5, 2026